BIOMARKER:

AR overexpression

Entrez ID:

Related biomarkers:

‹

›

AR overexpression AR overexpression	Triple Negative Breast Cancer Triple Negative Breast Cancer	TAK 700 Sensitive: C3 – Early Trials
AR overexpression AR overexpression	Prostate Cancer Prostate Cancer	enzalutamide Sensitive: C3 – Early Trials
AR overexpression AR overexpression	Triple Negative Breast Cancer Triple Negative Breast Cancer	enzalutamide Sensitive: C3 – Early Trials
AR overexpression AR overexpression	Breast Cancer Breast Cancer	paclitaxel Sensitive: C3 – Early Trials
AR overexpression AR overexpression	Estrogen Receptor Positive Breast Cancer Estrogen Receptor Positive Breast Cancer	RAD140 Sensitive: D – Preclinical
AR overexpression AR overexpression	Prostate Cancer Prostate Cancer	BMS-641988 Resistant: D – Preclinical